Clinical Trial Update: A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005 [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating adavosertib (MK1775) with 5-FU or 5-FU/cisplatin in advanced solid tumors; trial terminated with results posted in 2018…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• 5-FU (5-fluorouracil)
• Adavosertib (adavosertib)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2018-07-17